Tag: MRI
ESUI18: Prospects and impact of emerging imaging technologies
The rise of artificial intelligence, imaging-related toxicities, and other cutting-edge topics were featured during the session “Back to the future part I: What to expect in the next decade?”, which was moderated by Prof. Dr. Jurgen Futterer (NL), Prof....
PRECISION: MRI-targeted biopsy strategy leads to fewer men needing biopsy
A Magnetic Resonance Imaging (MRI)-targeted biopsy strategy results in fewer men needing biopsy, fewer biopsy cores required and more men with clinically significant cancer detected compared to standard transrectal ultrasound guided (TRUS) biopsy, according to the large international multicentre...
EMUC17: Improving reporting systems, defining selection criteria in PCa diagnosis
Despite gains in imaging technology and molecular research, pathologists engage in prostate cancer diagnosis are faced with dissimilar reporting systems and the lack of efficient selection criteria that are needed to further improve the accuracy of diagnosing prostate cancer...
Tumour characteristics and patient profile: Crucial issues in PCa treatment
Despite advances in diagnostic tools and imaging technologies, prostate cancer (PCa) management remains a challenge to many experts due to extensive variability in tumour characteristics and individual patient profiles which complicate the delivery of an optimal treatment plan. “There...
BALTIC17 looks into best practices in uro-oncology
Vilnius welcomed more than 250 participants to the 4th Baltic Meeting (BALTIC17) with the opening session focusing on best and current practices in diagnosing and managing urological cancers particularly the role of biopsy techniques, imaging tools, quality of life...
[SEEM16] mpMRI: A more accurate alternative to biopsy?
Multiparametric MRI (mpMRI) can help prevent overdiagnosis of prostate cancer. It can potentially replace biopsy in active surveillance, help avoid biopsies in low-risk patients with normal MRI, and reduce the number of cores per biopsy in prostate cancer treatment....
Using MRI before biopsy: A divisive topic?
Emerging technologies trigger new approaches. But with the perceived benefits of novel discoveries come the expected criticisms and contrary viewpoints. The issue of Magnetic Resonance Imaging (MRI) has prompted closer examination from both its adherents and critics during Thematic...
ESOU16, Day 1: The role of MRI in PCa diagnosis and active surveillance
Within five years, a standardized technique will be developed for deploying MRI in the diagnosis of prostate cancer. Urologists will be familiar with the PI-RADS (Prostate Imaging Reporting and Data System) scheme, and cooperate closely with better-trained radiologists in...
EMUC15: Examining new issues and challenges in prostate cancer
From precision grading, imaging, genomics to epidemiology, a range of issues that impact prostate cancer therapies were examined by a multidisciplinary team of experts which gathered today in Barcelona for the 7th European Multidisciplinary Meeting on Urological Cancers (EMUC15)....
Imaging in prostate cancer: Role of MRI to expand in the next decade
The role of imaging techniques such as multiparametric Magnetic Resonance Imaging (MP-MRI) will expand in the next few years and will have a more central role in the diagnosis of prostate cancer (PCa), particularly in cases when new technologies...